{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:57:00Z","timestamp":1791925020697,"version":"4.3.4"},"reference-count":158,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jhep.2013.03.015","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T20:31:26Z","timestamp":1366317086000},"page":"571-582","source":"Crossref","is-referenced-by-count":107,"title":["Update on primary sclerosing cholangitis"],"prefix":"10.1016","volume":"59","author":[{"given":"Tom H.","family":"Karlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Muri","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.03.015_b0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01879134","article-title":"Verschluss der gallenwege durch verdickung der wandungen","volume":"39","author":"Hoffman","year":"1867","journal-title":"Arch Pathol Anat Physiol"},{"key":"10.1016\/j.jhep.2013.03.015_b0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dld.2010.01.011","article-title":"Update on primary sclerosing cholangitis","volume":"42","author":"Karlsen","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0015","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000341122","article-title":"A lecture on the genetics of primary sclerosing cholangitis","volume":"30","author":"Karlsen","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0031-1276647","article-title":"Deciphering the genetic predisposition to primary sclerosing cholangitis","volume":"31","author":"Karlsen","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bpg.2011.09.010","article-title":"Genetics in primary sclerosing cholangitis","volume":"25","author":"Folseraas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clinre.2012.02.003","article-title":"Genetics in primary sclerosing cholangitis","volume":"36","author":"Naess","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0890","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jhep.2013.03.015_b0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar3204","article-title":"Promise and pitfalls of the Immunochip","volume":"13","author":"Cortes","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2013.03.015_b0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.21819","article-title":"Insights in the regulation of cholesterol 7 alpha-hydroxylase gene reveal a target for modulating bile acid synthesis","volume":"46","author":"Mitro","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0060","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1073\/pnas.1215450109","article-title":"Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages","volume":"109","author":"Clark","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.03.015_b0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0070","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3) (\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1074\/jbc.M110.164970","article-title":"Identification and functional characterization of TMEM16A, a Ca2+-activated Cl\u2212 channel activated by extracellular nucleotides, in biliary epithelium","volume":"286","author":"Dutta","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.03.015_b0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/bc.2010.077","article-title":"The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes","volume":"391","author":"Keitel","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.jhep.2013.03.015_b0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0095","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","article-title":"Induction of colitis in Cftr\u2212\/\u2212 mice results in bile duct injury","volume":"287","author":"Blanco","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2013.03.015_b0795","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0105","first-page":"1","article-title":"The glands of the bile and pancreatic ducts: autoradiographic and histochemical studies","volume":"95","author":"McMinn","year":"1961","journal-title":"J Anat"},{"key":"10.1016\/j.jhep.2013.03.015_b0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.1711280407","article-title":"The development of the glands of the common bile duct","volume":"128","author":"Spitz","year":"1979","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2013.03.015_b0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0800","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/j.gastro.2011.02.044","article-title":"Nuclear receptors as new perspective for the management of liver diseases","volume":"140","author":"Trauner","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0805","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2\u2212\/\u2212 (Abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0135","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.23708","article-title":"Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1","volume":"52","author":"Triantis","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract","volume":"55","author":"Zweers","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.03.015_b0155","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","article-title":"Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis","volume":"5","author":"Hov","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.03.015_b0160","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0165","doi-asserted-by":"crossref","first-page":"e25637","DOI":"10.1371\/journal.pone.0025637","article-title":"The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis","volume":"6","author":"Cipriani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.03.015_b0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2013.03.015_b0175","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.03.015_b0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.26019","article-title":"Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0185","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2010-0460","article-title":"The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling","volume":"25","author":"Li","year":"2011","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2013.03.015_b0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000324127","article-title":"TGR5 in the biliary tree","volume":"29","author":"Keitel","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0195","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1478-3231.2007.01465.x","article-title":"IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules","volume":"27","author":"Isse","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.03.015_b0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08916939709008028","article-title":"Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis","volume":"26","author":"Bansal","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jhep.2013.03.015_b0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2\u2212\/\u2212 (Abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO(\u2212)(3) output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0210","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","article-title":"Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis","volume":"131","author":"Karlsen","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0810","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25977","article-title":"Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4","author":"Ellinghaus","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0220","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1053\/j.gastro.2011.09.051","article-title":"Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury","volume":"142","author":"Moustafa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0225","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature11553","article-title":"Genomic approaches to studying the human microbiota","volume":"489","author":"Weinstock","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","author":"The Human Microbiome Project Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg3129","article-title":"Experimental and analytical tools for studying the human microbiome","volume":"13","author":"Kuczynski","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2013.03.015_b0240","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jhep.2013.03.015_b0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2540","article-title":"Unravelling the effects of the environment and host genotype on the gut microbiome","volume":"9","author":"Spor","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhep.2013.03.015_b0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2007.08.017","article-title":"Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system","volume":"131","author":"Garrett","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.03.015_b0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2012.10.052","article-title":"Xenobiotics shape the physiology and gene expression of the active human gut microbiome","volume":"15","author":"Maurice","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2013.03.015_b0260","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/hmg\/ddq248","article-title":"Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn\u2019s disease","volume":"19","author":"McGovern","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2013.03.015_b0265","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.1073\/pnas.1106408108","article-title":"Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (secretor) genotype","volume":"108","author":"Rausch","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2013.03.015_b0270","doi-asserted-by":"crossref","first-page":"e20113","DOI":"10.1371\/journal.pone.0020113","article-title":"Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine","volume":"6","author":"Wacklin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.03.015_b0275","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.221","article-title":"Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility","volume":"40","author":"Franke","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.03.015_b0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10\u2212\/\u2212 mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2013.03.015_b0290","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2013.03.015_b0295","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","article-title":"Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells","volume":"137","author":"Eksteen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0300","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/hep.24816","article-title":"Connecting liver and gut: murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid","volume":"55","author":"Neumann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0305","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.24085","article-title":"Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity","volume":"53","author":"Liaskou","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0310","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1196\/annals.1423.051","article-title":"Vascular adhesion protein-1 as a potential therapeutic target in liver disease","volume":"1110","author":"Lalor","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jhep.2013.03.015_b0315","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.25790","article-title":"Recruitment mechanisms of primary and malignant B cells to the human liver","volume":"56","author":"Shetty","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0320","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.4049\/jimmunol.0901216","article-title":"Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver","volume":"184","author":"Oo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2013.03.015_b0325","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/hep.23591","article-title":"CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium","volume":"51","author":"Aspinall","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0330","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0335","doi-asserted-by":"crossref","first-page":"19189","DOI":"10.1074\/jbc.M109.024042","article-title":"Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions","volume":"284","author":"Barth","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2013.03.015_b0340","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1521-6918(11)70005-1","article-title":"Novel developments in IBD-related sclerosing cholangitis","volume":"25","author":"Ponsioen","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0815","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26232","article-title":"IgG4+ clones identified by next-generation sequencing dominate the b-cell receptor repertoire in IgG4-associated cholangitis","author":"de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0820","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0031-1291540","article-title":"What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree","volume":"44","author":"Maillette de Buy Wenniger","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2013.03.015_b0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bpg.2007.10.014","article-title":"Autoimmune pancreatitis","volume":"22","author":"Dite","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0360","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.gie.2009.12.004","article-title":"IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis","volume":"71","author":"Moon","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2013.03.015_b0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-0030-1256872","article-title":"Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy","volume":"44","author":"Vosskuhl","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2013.03.015_b0370","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/hep.24487","article-title":"Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma","volume":"54","author":"Oseini","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0375","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulinG4: clinical characteristics and response to therapy","volume":"18","author":"Bjornsson","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.jhep.2013.03.015_b0380","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.dld.2011.05.009","article-title":"Immune-mediated diseases in primary sclerosing cholangitis","volume":"43","author":"Lamberts","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0825","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn\u2019s disease","volume":"6","author":"Halliday","year":"2012","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.jhep.2013.03.015_b0390","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/liv.12028","article-title":"Non-IBD immunological diseases are a risk factor for reduced survival in PSC","volume":"33","author":"Rupp","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.03.015_b0395","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0400","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2010.02.030","article-title":"In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival","volume":"53","author":"Rudolph","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0410","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ibd.20886","article-title":"More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Claessen","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0415","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0420","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/DCR.0b013e31822bbcc1","article-title":"Increased risk of colorectal cancer and dysplasia in patients with Crohn\u2019s colitis and primary sclerosing cholangitis","volume":"54","author":"Lindstrom","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jhep.2013.03.015_b0425","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.03.015_b0430","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0435","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","article-title":"Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study","volume":"32","author":"Fevery","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.03.015_b0440","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0445","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2011.10.002","article-title":"Primary sclerosing cholangitis and malignancy","volume":"25","author":"Boberg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0450","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0455","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOG.0b013e3282f5727a","article-title":"Gallbladder polyps in primary sclerosing cholangitis: not so benign","volume":"24","author":"Karlsen","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0465","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/hep.25589","article-title":"Gallbladder polyps in primary sclerosing cholangitis: indication for early intervention","volume":"56","author":"Schramm","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0470","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis","volume":"107","author":"Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0475","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19\u20139 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0480","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0485","first-page":"512","article-title":"Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients","volume":"58","author":"Narimatsu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2013.03.015_b0490","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1478-3231.2011.02672.x","article-title":"Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity","volume":"32","author":"Halme","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.03.015_b0830","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/ajg.2011.272","article-title":"Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma","volume":"106","author":"Barr Fritcher","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0835","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1309\/AJCPDULIOEOTUZ5H","article-title":"Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results","volume":"136","author":"Barr Fritcher","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jhep.2013.03.015_b0505","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0510","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0515","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0520","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0525","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2013.03.015_b0530","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1440-1746.2012.07109.x","article-title":"Pathogenesis and management of pruritus in cholestatic liver disease","volume":"27","author":"Imam","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0535","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2010.02.031","article-title":"Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers","volume":"53","author":"Pares","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0540","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0030-1253224","article-title":"Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy","volume":"30","author":"Pauli-Magnus","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0545","doi-asserted-by":"crossref","first-page":"e21850","DOI":"10.1371\/journal.pone.0021850","article-title":"Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus","volume":"6","author":"Gay","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2013.03.015_b0840","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0555","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI64551","article-title":"The TGR5 receptor mediates bile acid-induced itch and analgesia","volume":"123","author":"Alemi","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2013.03.015_b0560","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0565","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0570","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0575","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"Luth","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0580","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2013.03.015_b0585","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0590","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0595","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"Chambers","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2013.03.015_b0600","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0845","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","article-title":"Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis","volume":"58","author":"Al Mamari","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.12.032","article-title":"Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis","author":"Lindstrom","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0615","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis","volume":"43","author":"Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0620","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0625","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hep.20370","article-title":"Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis","volume":"40","author":"Rost","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0630","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/487047a","article-title":"Microbiology: fat, bile and gut microbes","volume":"487","author":"Turnbaugh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0635","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0640","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.03.015_b0895","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the Fecal Bile Acid Profile by Gut Microbiota in Cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0650","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2013.03.015_b0655","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10875-012-9801-1","article-title":"Immunomodulatory effect of vancomycin on treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","author":"Abarbanel","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhep.2013.03.015_b0660","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0665","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/039463200702000423","article-title":"Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation","volume":"20","author":"Boner","year":"2007","journal-title":"Int J Immunopathol Pharm"},{"key":"10.1016\/j.jhep.2013.03.015_b0670","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0675","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/gut.34.2.242","article-title":"Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin","volume":"34","author":"Sandborn","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.03.015_b0680","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.03.015_b0900","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"Jorgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.03.015_b0690","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gut.2009.186528","article-title":"Curcumin improves sclerosing cholangitis in Mdr2\u2212\/\u2212 mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation","volume":"59","author":"Baghdasaryan","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.03.015_b0695","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000324141","article-title":"Targeting nuclear bile acid receptors for liver disease","volume":"29","author":"Trauner","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0700","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/00365520701320521","article-title":"Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (\u2212\/\u2212) mice harbouring chronic cholangitis","volume":"42","author":"Nakken","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0705","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/bjc.2011.376","article-title":"A combination of serum leucine-rich alpha-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures","volume":"105","author":"Sandanayake","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2013.03.015_b0710","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0715","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2012-302047","article-title":"Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders","volume":"62","author":"Metzger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2013.03.015_b0720","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5858\/2007-131-923-MPOMCI","article-title":"Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas","volume":"131","author":"Kim","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhep.2013.03.015_b0725","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erm.12.39","article-title":"Epigenetic biomarkers in colorectal cancer diagnostics","volume":"12","author":"Rawson","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jhep.2013.03.015_b0865","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4161\/epi.22191","article-title":"Novel target genes and a valid biomarker panel identified for cholangiocarcinoma","volume":"7","author":"Andresen","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.jhep.2013.03.015_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0740","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.03.015_b0870","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.03.015_b0875","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?","volume":"215","author":"Rosen","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhep.2013.03.015_b0880","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep.25629","article-title":"Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma","volume":"56","author":"Darwish Murad","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.03.015_b0760","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365521.2010.533384","article-title":"Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results","volume":"46","author":"Friman","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.03.015_b0905","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/lt.23587","article-title":"Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis","volume":"19","author":"Goldberg","year":"2013","journal-title":"Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"},{"key":"10.1016\/j.jhep.2013.03.015_b0770","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00005176-200109000-00013","article-title":"Pediatric \u201cPSC-IBD\u201d: a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC","volume":"33","author":"Faubion","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2013.03.015_b0775","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2013.03.015_b0910","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0785","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2013.03.015_b0790","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813001931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813001931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:47:57Z","timestamp":1745992077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813001931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":158,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0168827813001931"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.03.015","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}